4.6 Article

Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy

Journal

BASIC RESEARCH IN CARDIOLOGY
Volume 116, Issue 1, Pages -

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-021-00896-2

Keywords

Cardioprotection; Cardiovascular magnetic resonance; Myocardial infarct size; Remote ischaemic conditioning

Funding

  1. British Heart Foundation Clinical Study Grant [CS/14/3/31002]
  2. University College London Hospital/University College London Biomedical Research Clinical Research grant
  3. Danish Innovation Foundation [11-108354, 11-115818]
  4. Novo Nordisk Foundation [NNF13OC0007447, NNF14OC0013337, NNF15OC0016674]
  5. Trygfonden [109624]
  6. British Heart Foundation [FS/10/039/28270]
  7. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  8. Duke-National University Singapore Medical School
  9. Singapore Ministry of Health's National Medical Research Council [NMRC/CSA-SI/0011/2017, NMRC/CGAug16C006]
  10. Health Research Fund of Central Denmark Region [A1000]
  11. British Heart Foundation (BHF)
  12. BHF Centre of Research Excellence Oxford
  13. NIHR Oxford BRC
  14. Alfred Benzon Foundation
  15. COST (European Cooperation in Science and Technology)
  16. COST Action EU-CARDIOPROTECTION [CA16225]

Ask authors/readers for more resources

The study found that limb remote ischaemic conditioning did not have a significant effect on myocardial infarct size and left ventricular ejection fraction. Cardiovascular magnetic resonance scans conducted both acutely and at 6 months showed no reduction in infarct size or improvement in heart function with limb RIC.
The effect of limb remote ischaemic conditioning (RIC) on myocardial infarct (MI) size and left ventricular ejection fraction (LVEF) was investigated in a pre-planned cardiovascular magnetic resonance (CMR) substudy of the CONDI-2/ERIC-PPCI trial. This single-blind multi-centre trial (7 sites in UK and Denmark) included 169 ST-segment elevation myocardial infarction (STEMI) patients who were already randomised to either control (n = 89) or limb RIC (n = 80) (4 x 5 min cycles of arm cuff inflations/deflations) prior to primary percutaneous coronary intervention. CMR was performed acutely and at 6 months. The primary endpoint was MI size on the 6 month CMR scan, expressed as median and interquartile range. In 110 patients with 6-month CMR data, limb RIC did not reduce MI size [RIC: 13.0 (5.1-17.1)% of LV mass; control: 11.1 (7.0-17.8)% of LV mass, P = 0.39], or LVEF, when compared to control. In 162 patients with acute CMR data, limb RIC had no effect on acute MI size, microvascular obstruction and LVEF when compared to control. In a subgroup of anterior STEMI patients, RIC was associated with lower incidence of microvascular obstruction and higher LVEF on the acute scan when compared with control, but this was not associated with an improvement in LVEF at 6 months. In summary, in this pre-planned CMR substudy of the CONDI-2/ERIC-PPCI trial, there was no evidence that limb RIC reduced MI size or improved LVEF at 6 months by CMR, findings which are consistent with the neutral effects of limb RIC on clinical outcomes reported in the main CONDI-2/ERIC-PPCI trial.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available